HIP AND OTHER FRACTURE RISK IN PATIENTS RECEIVING TERIPARATIDE IN REAL-WORLD CLINICAL PRACTICE: POOLED DATA FROM FOUR PROSPECTIVE OBSERVATIONAL STUDIES

被引：0

作者：

Silverman, S. L. ^{[1
,2
]}

Saag, K. G. ^{[3
]}

Langdahl, B. ^{[4
]}

Napoli, N. ^{[5
]}

Fujiwara, S. ^{[6
]}

Soen, S. ^{[7
]}

Disch, D. P. ^{[8
]}

Marin, F. ^{[9
]}

Enomoto, H. ^{[10
]}

Krege, J. H. ^{[8
]}

机构：

[1] Cedars Sinai UCLA Med Ctr, Beverly Hills, CA USA

[2] OMC Clin Res Ctr, Beverly Hills, CA USA

[3] Univ Alabama Birmingham, Birmingham, AL USA

[4] Aarhus Univ Hosp, Aarhus, Denmark

[5] Univ Campus Biomed, Rome, Italy

[6] Hiroshima Atom Bomb Casualty Council, Hlth Management & Promot Ctr, Hiroshima, Japan

[7] Kindai Univ, Dept Orthopaed Surg & Rheumatol, Nara Hosp, Ikoma City, Japan

[8] Eli Lilly & Co, Indianapolis, IN 46285 USA

[9] Lilly Res Ctr, Windlesham, Surrey, England

[10] Eli Lilly Japan KK, Kobe, Hyogo, Japan

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

OC36

引用

页码：S73 / S74

页数：2